Clinical Trial: A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413666) titled 'A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years' on Feb. 09.

Brief Summary: Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.

Study Start Date: Feb. 25

Study Type: INTERVENTIONAL

Condition: Healthy Adult Male and Female Volunteers

Intervention: DRUG: ORX489 Tablets

ORX489 Tablets

OTHER: Placebo Tablets

Placebo Tablets

Recruitment Status: RECRUITING

Sponsor: Centessa Pharmaceuticals (UK) Limited

Disclaimer: Curated by HT Syndication....